143 related articles for article (PubMed ID: 22707223)
1. Methylation pattern of oncogene HRAS gene promoter region and its clinical relevance to urocystic tumorigenesis.
Sun XF; Li L; Li XJ; Shen W
Mol Biol Rep; 2012 Aug; 39(8):8431-7. PubMed ID: 22707223
[TBL] [Abstract][Full Text] [Related]
2. Alteration in methylation pattern of oncogene Akt1 promoter region in bladder cancer.
Sun XF; Sun ZY; Pan B; Li L; Shen W
Mol Biol Rep; 2012 May; 39(5):5631-6. PubMed ID: 22189542
[TBL] [Abstract][Full Text] [Related]
3. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
4. Methylation of the SPARC gene promoter and its clinical implication in pancreatic cancer.
Gao J; Song J; Huang H; Li Z; Du Y; Cao J; Li M; Lv S; Lin H; Gong Y
J Exp Clin Cancer Res; 2010 Mar; 29(1):28. PubMed ID: 20338068
[TBL] [Abstract][Full Text] [Related]
5. Promoter hypomethylation as potential confounder of Ras gene overexpression and their clinical significance in subsets of urothelial carcinoma of bladder.
Tripathi K; Goel A; Singhai A; Garg M
Mol Biol Rep; 2021 Mar; 48(3):2183-2199. PubMed ID: 33620658
[TBL] [Abstract][Full Text] [Related]
6. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer.
Ribeiro-Filho LA; Franks J; Sasaki M; Shiina H; Li LC; Nojima D; Arap S; Carroll P; Enokida H; Nakagawa M; Yonezawa S; Dahiya R
Mol Carcinog; 2002 Aug; 34(4):187-98. PubMed ID: 12203370
[TBL] [Abstract][Full Text] [Related]
7. Impact of SNPs on CpG Islands in the MYC and HRAS oncogenes and in a wide variety of tumor suppressor genes: A multi-cancer approach.
Samy MD; Yavorski JM; Mauro JA; Blanck G
Cell Cycle; 2016 Jun; 15(12):1572-8. PubMed ID: 27074591
[TBL] [Abstract][Full Text] [Related]
8. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis.
Xu XL; Yu J; Zhang HY; Sun MH; Gu J; Du X; Shi DR; Wang P; Yang ZH; Zhu JD
World J Gastroenterol; 2004 Dec; 10(23):3441-54. PubMed ID: 15526363
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of normal and mutated forms of HRAS induces orthotopic bladder invasion in a human transitional cell carcinoma.
Theodorescu D; Cornil I; Fernandez BJ; Kerbel RS
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):9047-51. PubMed ID: 2247480
[TBL] [Abstract][Full Text] [Related]
10. RAS-mediated epigenetic inactivation of OPCML in oncogenic transformation of human ovarian surface epithelial cells.
Mei FC; Young TW; Liu J; Cheng X
FASEB J; 2006 Mar; 20(3):497-9. PubMed ID: 16384911
[TBL] [Abstract][Full Text] [Related]
11. G4-DNA formation in the HRAS promoter and rational design of decoy oligonucleotides for cancer therapy.
Membrino A; Cogoi S; Pedersen EB; Xodo LE
PLoS One; 2011; 6(9):e24421. PubMed ID: 21931711
[TBL] [Abstract][Full Text] [Related]
12. Methylation of a CpG island within the uroplakin Ib promoter: a possible mechanism for loss of uroplakin Ib expression in bladder carcinoma.
Varga AE; Leonardos L; Jackson P; Marreiros A; Cowled PA
Neoplasia; 2004; 6(2):128-35. PubMed ID: 15140401
[TBL] [Abstract][Full Text] [Related]
13. HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer.
Sugita S; Enokida H; Yoshino H; Miyamoto K; Yonemori M; Sakaguchi T; Osako Y; Nakagawa M
Int J Oncol; 2018 Aug; 53(2):725-736. PubMed ID: 29901113
[TBL] [Abstract][Full Text] [Related]
14. Methylation of PTCH1a gene in a subset of gastric cancers.
Du P; Ye HR; Gao J; Chen W; Wang ZC; Jiang HH; Xu J; Zhang JW; Zhang JC; Cui L
World J Gastroenterol; 2009 Aug; 15(30):3799-806. PubMed ID: 19673023
[TBL] [Abstract][Full Text] [Related]
15. Cross-generational effects of alcohol dependence in humans on HRAS and TP53 methylation in offspring.
Hill SY; Rompala G; Homanics GE; Zezza N
Epigenomics; 2017 Sep; 9(9):1189-1203. PubMed ID: 28799801
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
Liang Z; Wang X; Xu X; Xie B; Ji A; Meng S; Li S; Zhu Y; Wu J; Hu Z; Lin Y; Zheng X; Xie L; Liu B
Mol Cancer; 2017 May; 16(1):96. PubMed ID: 28549468
[TBL] [Abstract][Full Text] [Related]
17. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing.
Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA
Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622
[TBL] [Abstract][Full Text] [Related]
18. CpG hypermethylation of collagen type I alpha 2 contributes to proliferation and migration activity of human bladder cancer.
Mori K; Enokida H; Kagara I; Kawakami K; Chiyomaru T; Tatarano S; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Int J Oncol; 2009 Jun; 34(6):1593-602. PubMed ID: 19424577
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation-regulated QPCT promotes sunitinib resistance by increasing HRAS stability in renal cell carcinoma.
Zhao T; Bao Y; Gan X; Wang J; Chen Q; Dai Z; Liu B; Wang A; Sun S; Yang F; Wang L
Theranostics; 2019; 9(21):6175-6190. PubMed ID: 31534544
[No Abstract] [Full Text] [Related]
20. LMP gene promoter hypermethylation is a mechanism for its down regulation in Kazak's esophageal squamous cell carcinomas.
Zheng F; Hasim A; Anwer J; Niyaz M; Sheyhidin I
Mol Biol Rep; 2013 Mar; 40(3):2069-75. PubMed ID: 23283737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
